A pregnant woman presents with a new trunk rash; how should it be evaluated and managed?

Evaluation and Management of Trunk Rash in Pregnancy

A pregnant woman with a new trunk rash requires immediate evaluation to distinguish between benign pregnancy-specific dermatoses and potentially serious conditions like intrahepatic cholestasis of pregnancy (ICP) or pemphigoid gestationis that carry fetal risks including prematurity and stillbirth 1.

Critical Initial Assessment

The evaluation must focus on identifying high-risk conditions that threaten fetal outcomes:

Red Flag Features to Identify Immediately

Intrahepatic Cholestasis of Pregnancy (ICP):

• Begins with intense pruritus, particularly affecting the palms and soles 2
• Skin changes are secondary to scratching, not primary 1
• This condition carries significant fetal risks including stillbirth and requires urgent obstetric involvement

Pemphigoid Gestationis:

• Look for periumbilical involvement with blistering eruptions 2
• Associated with prematurity and fetal complications 1
• Requires direct immunofluorescence showing linear complement deposition along the basement membrane for diagnosis 3

Lower-Risk Pregnancy Dermatoses

Polymorphic Eruption of Pregnancy:

• Presents in striae distensae (stretch marks) 2
• Characteristically spares the umbilicus 2
• No fetal risk

Atopic Eruption of Pregnancy:

• Eczematous changes, often with history of atopy 4
• No fetal risk

Prurigo of Pregnancy:

• Highly itchy papulonodules primarily on extensor surfaces of extremities and dorsum of hands/feet 5
• Variable distribution possible 5

Diagnostic Algorithm

1. Assess pruritus pattern: If intense pruritus precedes rash, especially on palms/soles → suspect ICP, obtain liver function tests and bile acids urgently

2. Examine rash distribution:

   • Periumbilical blistering → pemphigoid gestationis (requires skin biopsy with direct immunofluorescence)
   • Within striae, sparing umbilicus → polymorphic eruption of pregnancy
   • Extensor surfaces → prurigo of pregnancy

3. If blistering present: Perform skin biopsy with direct immunofluorescence to confirm pemphigoid gestationis 3

Management Approach

For ICP (if confirmed):

• Immediate obstetric referral for fetal monitoring
• Ursodeoxycholic acid treatment
• Plan for early delivery

For Pemphigoid Gestationis:

• Dermatology consultation
• Neonatal monitoring required 4
• Treatment with topical/oral corticosteroids

For Benign Pregnancy Dermatoses:

First-line treatment should be chlorphenamine (chlorpheniramine) if antihistamine therapy is necessary, as it has the longest safety record in pregnancy 6. Hydroxyzine is specifically contraindicated in early pregnancy 6.

Alternative safer antihistamines include:

• Loratadine or cetirizine (FDA Pregnancy Category B) 6
• These have no evidence of fetal harm, though well-controlled human studies are lacking

Additional treatments for benign dermatoses 5:

• Topical corticosteroids
• Emollients
• Narrow-band UVB phototherapy for refractory cases
• Short courses of oral corticosteroids if severe

Critical Pitfalls to Avoid

• Do not dismiss pruritus without rash - this may be ICP, which requires urgent intervention
• Do not use hydroxyzine in pregnancy, particularly first trimester 6
• Do not delay skin biopsy with immunofluorescence if blistering is present - pemphigoid gestationis requires specific diagnosis and fetal monitoring
• Avoid all antihistamines in first trimester when possible 6, but if treatment is necessary, chlorphenamine is preferred

The key distinction is identifying conditions with fetal risk (ICP and pemphigoid gestationis) versus benign pregnancy dermatoses. When in doubt about diagnosis, dermatology and obstetric consultation should be obtained promptly rather than empirically treating.